Latest filing published 17 Mar 2026 for Immuneering Corp, €14k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +21.6%Entry US$4.58 · Close at T+90 US$5.57
- -36.2%Entry US$6.05 · Close 07 Oct 2026 US$3.86
- +38.3%Entry US$4.00 · Close at T+365 US$5.53
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Leah R. Neufeld: trading record in brief
Leah R. Neufeld appears in our data through filings on Immuneering Corp shares, published by SEC (Form 4). Between 15 March 2024 and 13 March 2026, the trades on record add up to 7 filings.
On the market, this insider has only ever bought: 4 purchases, €26k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants. Since January 2026: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €6,848. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +21.6%. This is a record of the past, not a forecast.
The newest entry dates from 17 March 2026: a share grant of €14k, in Immuneering Corp. The clock since the last published purchase (15 January 2026) now reads 298 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Leah R. Neufeld
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,628 shares@ US$4.292525.5% of flowClass A Common StockSEC:0001790340-26-000044:0
- 2,626 shares@ US$4.15317.7% of flowClass A Common StockSEC:0001790340-26-000010:0Canonical exit: 13 Apr 2026 (T+90)
- 800 shares@ US$6.37928.2% of flowClass A Common StockSEC:0001790340-25-000123:0Canonical exit: 30 Dec 2025 (T+90)
- 11,815 shares@ US$1.42827.1% of flowClass A Common StockSEC:0001790340-25-000115:0
- 700 shares@ US$3.56954.0% of flowClass A Common StockSEC:0001790340-25-000096:0Canonical exit: 30 Sept 2025 (T+90)
- 6,211 shares@ US$1.6217.5% of flowClass A Common StockSEC:0001790340-24-000036:0
6 of 6 declarations
